Genetic Studies of X-linked Lymphoproliferative Disease
|ClinicalTrials.gov Identifier: NCT00359411|
Recruitment Status : Completed
First Posted : August 2, 2006
Last Update Posted : July 2, 2017
This study will study the effects of the gene on the X chromosome that is associated with X-linked lymphoproliferative disease (XLPD)-an inherited disease affecting the immune system-on the function of the immune system. XLPD has been linked to an abnormality in a specific region of the X chromosome (one of 23 chromosome pairs that contain the genes that determine a person's hereditary makeup). The disease may develop after infection with the Epstein-Barr virus (EBV). EBV affects more than 95 percent of people in the United States. It usually does not cause any symptoms in children. In adolescents and adults, however, EBV can cause infectious mononucleosis and sometimes lymphoproliferative disease, such as XLPD. In these diseases lymph tissues, such as lymph nodes, may become enlarged and immune function (infection-fighting ability) impaired. This study will compare DNA from patients with XLPD with that of their unaffected relatives, of patients with other lymphoproliferative diseases and of normal controls.
Patients of any age with XLPD, their unaffected relatives 18 years of age and older, and patients with other lymphoproliferative diseases may participate in this study.
Blood samples will be collected from all participants to study the effects of the gene on the X chromosome that appears to be abnormal in XLPD on the function of the immune system. In a 6-week period, no more than 100 milliliters (about 7 tablespoons) of blood will be drawn from adults and no more than 1 ml (1/6 teaspoon) of blood per pound of body weight from children. Blood from patients with XLPD and their relatives will also be tested for HLA type (similar to blood type testing) and the ability of HLA-matched cells from patients and relatives to interact will be examined.
|Condition or disease|
|X-Linked Lymphoproliferative Disease Lymphoproliferative Disease Genetic Diseases, X-Linked|
|Study Type :||Observational|
|Actual Enrollment :||12 participants|
|Official Title:||Genetic Studies of the X-Linked Lymphoproliferative Disease|
|Study Start Date :||May 22, 1996|
|Estimated Study Completion Date :||February 1, 2010|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00359411
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|